Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 62Neoplasms 52Neoplasm Metastasis 49Leukemia, Myeloid, Acute 48Colorectal Neoplasms 48Breast Neoplasms 44Prostatic Neoplasms 38Multiple Myeloma 34Ovarian Neoplasms 32Recurrence 29Melanoma 28Pancreatic Neoplasms 27Lymphoma, Non-Hodgkin 26Squamous Cell Carcinoma of Head and Neck 24Precursor Cell Lymphoblastic Leukemia-Lymphoma 24Myelodysplastic Syndromes 22Endometrial Neoplasms 22Triple Negative Breast Neoplasms 21Glioblastoma 20Carcinoma, Renal Cell 20Lung Neoplasms 19Advanced Solid Tumors 19Stomach Neoplasms 18Small Cell Lung Carcinoma 18Sarcoma 18Carcinoma, Hepatocellular 17Brain Neoplasms 17Lymphoma, B-Cell 14Esophageal Neoplasms 13Advanced Solid Tumor 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Multiple Sclerosis × 30 days × Clear all
NCT06680037 2026-05-18

A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders

TG Therapeutics, Inc.

Phase 1 Recruiting
100 enrolled

Multiple Sclerosis, Myasthenia Gravis, Neuromyelitis Optica, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡